Great Lakes Advisors’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.9M Sell
41,339
-24,240
-37% -$1.17M 0.02% 364
2026
Q2
$3.85M Buy
65,579
+7,579
+13% +$318K 0.03% 289
2026
Q1
$1.87M Sell
58,000
-71
-0.1% -$2.63K 0.02% 424
2025
Q4
$2.44M Hold
58,071
– – 0.02% 389
2025
Q3
$1.99M Sell
58,071
-8,162
-12% -$234K 0.02% 431
2025
Q2
$1.79M Sell
66,233
-2,777
-4% -$80.4K 0.02% 468
2025
Q1
$2.05M Sell
69,010
-21,107
-23% -$805K 0.02% 437
2024
Q4
$3.57M Sell
90,117
-48,001
-35% -$1.82M 0.03% 398
2024
Q3
$4.7M Sell
138,118
-1,572
-1% -$44.2K 0.04% 348
2024
Q2
$3.03M Sell
139,690
-287
-0.2% -$6.03K 0.03% 413
2024
Q1
$3.1M Buy
+139,977
New +$3.41M 0.03% 412

Other funds holding VCYT

Great Lakes Advisors's VCYT Position: Q3 2026 in Review

Great Lakes Advisors reduced its Veracyte (VCYT) stake by 37% in Q3 2026, selling an estimated $1.17M and leaving 41,339 shares worth $1.9M. The position accounts for 0.02% of the portfolio, ranked #364.

Great Lakes Advisors first reported a position in VCYT in Q1 2024 and has held it in 11 quarters since. The position peaked at $4.7M in Q3 2024. 201 funds tracked by Wall St. Rank hold VCYT as of Q3 2026.

  • Great Lakes Advisors held 41,339 shares of Veracyte worth $1.9M as of Q3 2026.
  • Great Lakes Advisors sold 24,240 Veracyte shares in Q3 2026, an estimated $1.17M.
  • Veracyte made up 0.02% of Great Lakes Advisors's portfolio in Q3 2026, its #364 holding.
  • Great Lakes Advisors first reported a position in Veracyte in Q1 2024 and has held it in 11 quarters since.
  • Great Lakes Advisors's Veracyte position peaked at $4.7M in Q3 2024.
  • 201 funds tracked by Wall St. Rank held Veracyte as of Q3 2026.

Based on Great Lakes Advisors's 13F filing for Q3 2026, filed 6 Nov 2026.